Previous study has shown that reduced T cell response to
peptide alpha 146-162 of Torpedo californica
acetylcholine receptor (tAChR) in B6.C-H-2bm12 (bm12) mice, a mutant of C57BL/6 (B6) mice, correlated with its nonsusceptiblity to
experimental autoimmune myasthenia gravis. There are three
amino acid differences between the I-A beta b of the two strains (positions 67, 70, and 71). We synthesized
peptides I-A beta b62-76 (
peptide b6), I-A beta bm1262-76 (
peptide bm), and three additional
peptides, b6(67F), b6(70Q), and b6(71K), and determined their ability to bind
peptide alpha 146-162 and the dissociation constants (Kd) of the binding.
Peptide alpha 146-162 bound with a significantly higher affinity to
peptide b6 than to
peptides bm or b6(71K), suggesting that the lower affinity of
peptide alpha 146-162 to I-Abm12 is
a factor in the reduced response to this
peptide by bm12 T cells. This was confirmed by measurement of the Kd values of the binding of
peptide alpha 146-162 to the I-A molecules of B6 and bm12. Furthermore, APC of bm12 presented the
peptide, or tAChR, poorly to
peptide-specific or to tAChR-specific B6 T cells. The major effect is caused by the change of Thr-71 in I-A beta b to
lysine in I-A beta bm12. However, APC of B6 also presented
peptide alpha 146-162 much less efficiently to
peptide-specific T cells of bm12. This demonstrated that these three
amino acid changes also influence the
T cell receptor recognition of
peptide-MHC complex and that both B6 and bm12 T cells recognizing
peptide alpha 146-162 or tAChR are under a high H-2 restriction.